Alkeran (Melphalan) for Myeloma | MyMyelomaTeam

Connect with others who understand.

sign up Log in
About MyMyelomaTeam
Powered By

Alkeran is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma. Alkeran is often combined with other drugs such as Velcade or Thalomid and a corticosteroid. Alkeran is also known by its drug name, melphalan.

Alkeran is an anti-cancer drug used in chemotherapy. Alkeran is a member of a class of drugs called alkylating agents. Alkeran is believed to work by preventing the production of DNA in cells, blocking cell division.

How do I take it?
Alkeran is taken orally once a day.

Alkeran is available as a tablet.

Side effects
The FDA-approved label for Alkeran lists common side effects including decreased blood count, mouth sores, nausea, vomiting, diarrhea, temporary hair loss, skin rash, itching, increased risk for infection, and anemia.

Rare but serious side effects listed for Alkeran include severe lung damage, hepatitis, hypersensitivity reactions, and the risk of permanent infertility in both men and women.

For more details about this treatment, visit:

Alkeran — RxList

Drug Therapy for Multiple Myeloma — American Cancer Society

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in